Prognostic Value of Circulating Fibrosis Biomarkers in Dilated Cardiomyopathy (DCM): Insights into Clinical Outcomes
Background: Dilated cardiomyopathy (DCM) involves myocardial remodeling, characterized by significant fibrosis and extracellular matrix expansion. These changes impair heart function, increasing the risk of heart failure and sudden cardiac death. This study investigates the prognostic value of circu...
Saved in:
| Main Authors: | Elham Kayvanpour, Farbod Sedaghat-Hamedani, Daniel Tian Li, Tobias Miersch, Tanja Weis, Imo Hoefer, Norbert Frey, Benjamin Meder |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-09-01
|
| Series: | Biomolecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-273X/14/9/1137 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Personalized care in dilated cardiomyopathy: Rationale and study design of the activeDCM trial
by: Farbod Sedaghat‐Hamedani, et al.
Published: (2024-12-01) -
Predictors of heart failure in patients with cardiomyopathies of various origins
by: O. O. Kuznetsova, et al.
Published: (2023-11-01) -
Characterization and natural history of patients with LMNA‐related dilated cardiomyopathy in the phase 3 REALM‐DCM trial
by: Pablo Garcia‐Pavia, et al.
Published: (2024-12-01) -
Immunohistochemical characteristics of MMP-9 and TIMP-1 markers expression in the cerebral cortex in diabetes mellitus type 2
by: V. O. Shavrin, et al.
Published: (2020-08-01) -
Genomic structural variations lead to dysregulation of important coding and non‐coding RNA species in dilated cardiomyopathy
by: Jan Haas, et al.
Published: (2017-11-01)